Not applicableStudy completedNCT05054114
What this trial is testing
Study of the Use of Nasal IFN-γ in Patients for the Prevention of Acute Respiratory Viral Infections, Icluding COVID-19
Who this might be right for
COVID-19 Respiratory InfectionAcute Respiratory Disease
SPP Pharmaclon Ltd. 630